• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Epitel Closes $26M to Commercialize REMI Remote EEG Platform

by Jasmine Pennic 08/04/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Epitel Closes $26M to Commercialize REMI Remote EEG Platform

What You Should Know

  • Salt Lake City-based digital health innovator Epitel, Inc. closed a $26M Series B funding round co-led by Catalyst Health Ventures and Genoa Ventures.
  • The Series B financing supports the nationwide commercial footprint expansion of Epitel’s REMI® Remote EEG Monitoring System and REMI Vigilenz™ AI For Event Detection.
  • Out of 9.2 million Americans experiencing seizures annually, 40% lack basic EEG access—largely because only 27% of U.S. hospitals possess native EEG diagnostic capacity.
  • Traditional inpatient or ambulatory EEG is constrained to 72-hour monitoring periods, whereas REMI’s wireless wearable sensors capture continuous brain activity at home over multiple weeks.
  • Backed by five FDA 510(k) clearances, REMI is cleared for neurological monitoring in pediatric patients as young as one year old, with AI event detection cleared for patients aged six and older.

Bypassing Hospital EEG Capacity Deficits: Epitel Scales Wearable Seizure Monitoring Across Weeks

Epitel has secured $26M in Series B financing to scale its wireless, remote electroencephalography (EEG) platform, targeting the diagnostic limitations and access gaps of traditional inpatient brain monitoring. Co-led by Catalyst Health Ventures and Genoa Ventures, the capital will expand commercial operations and field sales for Epitel’s FDA-cleared REMI® Remote EEG Monitoring System across ambulatory clinics and health systems nationwide.

In the U.S., an estimated 9.2 million people experience seizures each year, yet roughly 40% lack access to routine EEG testing—largely because only 27% of acute care hospitals maintain dedicated EEG diagnostic capacity. Furthermore, because seizure activity can occur weeks apart without visible clinical signs, standard 72-hour tethered hospital recordings frequently miss critical events, delaying definitive diagnoses by months or years.

Epitel’s REMI platform addresses these limitations by replacing wired head caps with lightweight, wearable sensors that record continuous EEG data at home over several weeks. The system incorporates REMI Vigilenz™ AI, an automated event-detection tool that reviews multi-week recordings to flag potential seizure activity for physician evaluation. The platform holds five FDA 510(k) clearances, covering neurological monitoring in pediatric patients as young as 1 year old and AI-assisted event detection for patients aged 6 and older.

By shifting brain monitoring from brief, inpatient snapshots to extended ambulatory datasets, the platform helps neurology practices increase diagnostic yields without adding physical bed capacity or overburdening clinical staff with raw data review.

“Millions of Americans with suspected seizures still face significant barriers to diagnosis because access to EEG remains limited, particularly outside major medical centers,” said Steve Pacelli, President and CEO of Epitel. “We built the REMI System to help close that gap by bringing longer-term neurological monitoring closer to patients and helping clinicians efficiently review the data needed to make a diagnosis.”


  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |